Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leukemia, Myelomonocytic, Juvenile × Busulfan × Clear all

Phase

Phase 2 14 Phase NA 3 Phase 1 2 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Myelodysplastic Syndromes 2 Recurrence 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Lymphoid 1 Leukemia 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01339988 2011-04-21

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon ⚡